OHWA
ABBV icon

Oak Hill Wealth Advisors’s AbbVie ABBV Stock Holding History

Oak Hill Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,109
Closed -$3.38M – 135
2024
Q3 		$3.38M Buy
+17,109
New +$3.19M 0.83% 25
2024
Q2 		– Sell
-17,145
Closed -$3.12M – 116
2024
Q1 		$3.12M Buy
+17,145
New +$2.95M 1% 15

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Hill Wealth Advisors's ABBV Position: Q3 2025 in Review

Oak Hill Wealth Advisors reduced its AbbVie (ABBV) stake by 0.62% in Q3 2025, selling an estimated $22K and leaving 17,395 shares worth $4.03M. The position accounts for 0.75% of the portfolio, ranked #25.

Oak Hill Wealth Advisors first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Oak Hill Wealth Advisors held 17,395 shares of AbbVie worth $4.03M as of Q3 2025.
  • Oak Hill Wealth Advisors sold 108 AbbVie shares in Q3 2025, an estimated $22K.
  • AbbVie made up 0.75% of Oak Hill Wealth Advisors's portfolio in Q3 2025, its #25 holding.
  • Oak Hill Wealth Advisors first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Oak Hill Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.